We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+24.25%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$64.3B
AUM Growth
+$9.38B
(+17%)
Cap. Flow
-$1.88B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
13.59%
Holding
699
New
57
Increased
192
Reduced
352
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$357M |
| 2 |
AbbVie
ABBV
|
+$264M |
| 3 |
Allison Transmission
ALSN
|
+$258M |
| 4 |
Amgen
AMGN
|
+$220M |
| 5 |
Goldman Sachs
GS
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$282M |
| 2 |
Pfizer
PFE
|
+$259M |
| 3 |
Merck
MRK
|
+$245M |
| 4 |
Kimberly-Clark
KMB
|
+$229M |
| 5 |
FirstEnergy
FE
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.93% |
| 2 | Industrials | 15.47% |
| 3 | Healthcare | 15.43% |
| 4 | Technology | 13.03% |
| 5 | Consumer Discretionary | 12.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Bank OZK
OZK
$5.62B
| $1.27M | ﹤0.01% |
40,737
-3,451
| -8% | -$93.2K |
|
502
Zebra Technologies
ZBRA
$13.5B
| $1.27M | ﹤0.01% |
3,307
-2,779
| -46% | -$935K |
|
503
Orion Group Holdings
ORN
$485M
| $1.26M | ﹤0.01% |
253,350
-109,561
| -30% | -$425K |
|
504
Matthews International
MATW
$900M
| $1.25M | ﹤0.01% |
42,632
-102,464
| -71% | -$2.65M |
|
505
Snap-on
SNA
$21.7B
| $1.25M | ﹤0.01% |
7,294
-1,161
| -14% | -$194K |
|
506
AdvanSix
ASIX
$551M
| $1.24M | ﹤0.01% |
62,027
-22,359
| -26% | -$383K |
|
507
JD.com
JD
$42.9B
| $1.24M | ﹤0.01% |
14,069
-1,137
| -7% | -$95K |
|
|
FFIC
508
DELISTED
Flushing Financial
FFIC
| $1.24M | ﹤0.01% |
74,280
-1,413
| -2% | -$19.6K |
|
509
UFP Industries
UFPI
$5.14B
| $1.22M | ﹤0.01% |
22,015
-1,865
| -8% | -$102K |
|
|
DSPG
510
DELISTED
DSP Group Inc
DSPG
| $1.22M | ﹤0.01% |
73,337
+32,610
| +80% | +$502K |
|
511
Akamai
AKAM
$16.3B
| $1.21M | ﹤0.01% |
11,534
-3,572
| -24% | -$374K |
|
512
Insperity
NSP
$2.01B
| $1.21M | ﹤0.01% |
14,802
-1,256
| -8% | -$103K |
|
513
Hackett Group
HCKT
$266M
| $1.2M | ﹤0.01% |
83,363
-7,061
| -8% | -$97.9K |
|
514
El Pollo Loco
LOCO
$497M
| $1.2M | ﹤0.01% |
66,301
+9,704
| +17% | +$163K |
|
515
Lincoln National
LNC
$8.19B
| $1.2M | ﹤0.01% |
23,786
-14,697
| -38% | -$625K |
|
|
NTUS
516
DELISTED
Natus Medical Inc
NTUS
| $1.19M | ﹤0.01% |
+59,399
| New | +$1.16M |
|
|
ECHO
517
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.19M | ﹤0.01% |
44,348
+24,279
| +121% | +$684K |
|
|
HOUS
518
DELISTED
Anywhere Real Estate
HOUS
| $1.19M | ﹤0.01% |
90,654
-273,846
| -75% | -$3.27M |
|
519
Gibraltar Industries
ROCK
$1.39B
| $1.18M | ﹤0.01% |
16,444
-8,674
| -35% | -$579K |
|
|
EVRI
520
DELISTED
Everi Holdings
EVRI
| $1.18M | ﹤0.01% |
85,285
-44,243
| -34% | -$481K |
|
|
LTRPA
521
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.16M | ﹤0.01% |
+267,400
| New | +$724K |
|
522
US Bancorp
USB
$100B
| $1.16M | ﹤0.01% |
24,831
+5,146
| +26% | +$218K |
|
|
CNBKA
523
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.16M | ﹤0.01% |
14,934
| – | – |
|
|
CTO
524
CTO Realty Growth
CTO
$740M
| $1.15M | ﹤0.01% |
81,903
-43,040
| -34% | -$567K |
|
|
SIVB
525
DELISTED
SVB Financial Group
SIVB
| $1.15M | ﹤0.01% |
2,963
-712
| -19% | -$231K |
|
Similar funds
Boston Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Boston Partners held 699 positions worth $64.3B, up 17% from $54.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q4 2020 filing shows 57 new, 192 increased, 352 reduced and 81 closed positions. Its largest new stake was Boeing: 1,856,421 shares worth $397M. The largest sale was JPMorgan Chase, an estimated $282M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Boston Partners's largest Q4 2020 buy was Boeing: 1,856,421 shares worth $397M.
- Boston Partners added most to AbbVie in Q4 2020, an estimated $264M increase.
- Boston Partners's biggest Q4 2020 reduction was JPMorgan Chase, cutting an estimated $282M.
- Boston Partners fully exited Kimberly-Clark in Q4 2020, selling an estimated $229M.
- Boston Partners's ten largest holdings make up 14% of its $64.3B portfolio in Q4 2020.
- Boston Partners opened 57 new positions and closed 81 in Q4 2020.
- Boston Partners's portfolio value rose 17% quarter-over-quarter to $64.3B.
Based on Boston Partners's 13F filing for Q4 2020, filed 4 Feb 2021.